These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 11210963)

  • 1. Selective drug resistant human osteosarcoma cell lines.
    Burns BS; Edin ML; Lester GE; Tuttle HG; Wall ME; Wani MC; Bos GD
    Clin Orthop Relat Res; 2001 Feb; (383):259-67. PubMed ID: 11210963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative in vitro cytotoxicity of taxol and Taxotere against cisplatin-sensitive and -resistant human ovarian carcinoma cell lines.
    Kelland LR; Abel G
    Cancer Chemother Pharmacol; 1992; 30(6):444-50. PubMed ID: 1356649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro cross-resistance and collateral sensitivity in seven resistant small-cell lung cancer cell lines: preclinical identification of suitable drug partners to taxotere, taxol, topotecan and gemcitabin.
    Jensen PB; Holm B; Sorensen M; Christensen IJ; Sehested M
    Br J Cancer; 1997; 75(6):869-77. PubMed ID: 9062409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of taxol and taxotere in comparison with doxorubicin and cisplatin on primary cell cultures of human breast cancers.
    Zoli W; Flamigni A; Frassineti GL; Bajorko P; De Paola F; Milandri C; Amadori D; Gasperi-Campani A
    Breast Cancer Res Treat; 1995 Apr; 34(1):63-9. PubMed ID: 7749161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrinsic resistance to chemotherapeutic agents in murine osteosarcoma cells.
    Takeshita H; Kusuzaki K; Ashihara T; Gebhardt MC; Mankin HJ; Hirasawa Y
    J Bone Joint Surg Am; 2000 Jul; 82-A(7):963-9. PubMed ID: 10901311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Taxol and taxotere in bladder cancer: in vitro activity and urine stability.
    Rangel C; Niell H; Miller A; Cox C
    Cancer Chemother Pharmacol; 1994; 33(6):460-4. PubMed ID: 7907952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential cytotoxic effects of docetaxel in a range of mammalian tumor cell lines and certain drug resistant sublines in vitro.
    Hill BT; Whelan RD; Shellard SA; McClean S; Hosking LK
    Invest New Drugs; 1994; 12(3):169-82. PubMed ID: 7896535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of both p185c-erbB2 and p170mdr-1 renders breast cancer cells highly resistant to taxol.
    Yu D; Liu B; Jing T; Sun D; Price JE; Singletary SE; Ibrahim N; Hortobagyi GN; Hung MC
    Oncogene; 1998 Apr; 16(16):2087-94. PubMed ID: 9572489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental models for the study of drug resistance in osteosarcoma: P-glycoprotein-positive, murine osteosarcoma cell lines.
    Takeshita H; Gebhardt MC; Springfield DS; Kusuzaki K; Mankin HJ
    J Bone Joint Surg Am; 1996 Mar; 78(3):366-75. PubMed ID: 8613443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of orally active taxanes on P-glycoprotein modulation and colon and breast carcinoma drug resistance.
    Vredenburg MR; Ojima I; Veith J; Pera P; Kee K; Cabral F; Sharma A; Kanter P; Greco WR; Bernacki RJ
    J Natl Cancer Inst; 2001 Aug; 93(16):1234-45. PubMed ID: 11504769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor activity of taxotere (RP 56976, NSC 628503), a new taxol analog, in experimental ovarian cancer.
    Boven E; Venema-Gaberscek E; Erkelens CA; Bissery MC; Pinedo HM
    Ann Oncol; 1993 Apr; 4(4):321-4. PubMed ID: 8100146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Taxoids: effective agents in anthracycline-resistant breast cancer.
    Ravdin PM
    Semin Oncol; 1995 Dec; 22(6 Suppl 13):29-34. PubMed ID: 8604450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 'Rings' of F-actin form around the nucleus in cultured human MCF7 adenocarcinoma cells upon exposure to both taxol and taxotere.
    Rosenblum MD; Shivers RR
    Comp Biochem Physiol C Toxicol Pharmacol; 2000 Jan; 125(1):121-31. PubMed ID: 11790336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of taxotere-related drug resistance in pancreatic carcinoma.
    Liu B; Staren ED; Iwamura T; Appert HE; Howard JM
    J Surg Res; 2001 Aug; 99(2):179-86. PubMed ID: 11469885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomic investigation of taxol and taxotere resistance and invasiveness in a squamous lung carcinoma cell line.
    Murphy L; Henry M; Meleady P; Clynes M; Keenan J
    Biochim Biophys Acta; 2008 Sep; 1784(9):1184-91. PubMed ID: 18503785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro cytotoxic activity of Taxol and Taxotere on primary cultures and established cell lines of human ovarian cancer.
    Silvestrini R; Zaffaroni N; Orlandi L; Oriana S
    Stem Cells; 1993 Nov; 11(6):528-35. PubMed ID: 7906583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemistry and chemical biology of taxane anticancer agents.
    Miller ML; Ojima I
    Chem Rec; 2001; 1(3):195-211. PubMed ID: 11895119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative effects of taxol and Taxotere on two different human carcinoma cell lines.
    Garcia P; Braguer D; Carles G; el Khyari S; Barra Y; de Ines C; Barasoain I; Briand C
    Cancer Chemother Pharmacol; 1994; 34(4):335-43. PubMed ID: 7913421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting ABCB1 and ABCC1 with their Specific Inhibitor CBT-1® can Overcome Drug Resistance in Osteosarcoma.
    Fanelli M; Hattinger CM; Vella S; Tavanti E; Michelacci F; Gudeman B; Barnett D; Picci P; Serra M
    Curr Cancer Drug Targets; 2016; 16(3):261-74. PubMed ID: 26548759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of tubulin-inhibiting agents in human lung and breast cancer cell lines with different multidrug resistance phenotypes.
    van Ark-Otte J; Samelis G; Rubio G; Lopez Saez JB; Pinedo HM; Giaccone G
    Oncol Rep; 1998; 5(1):249-55. PubMed ID: 9458331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.